Tocolizumab improves remission rates in giant-cell arteritis: The GiACTA trial – 2 Minute Medicine

Tocolizumab improves remission rates in giant-cell arteritis: The GiACTA trial – 2 Minute Medicine

Tocolizumab improves remission rates in giant-cell arteritis: The GiACTA trial – 2 Minute Medicine
Published on 2017-07-26